Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:cancer_treatment
|
| gptkbp:benefits |
improves patient outcomes
|
| gptkbp:clinical_trial |
Phase 1
|
| gptkbp:developed_by |
Synlogic
|
| https://www.w3.org/2000/01/rdf-schema#label |
SYN-020
|
| gptkbp:mechanism_of_action |
modulates immune response
|
| gptkbp:research_focus |
oncology
|
| gptkbp:route_of_administration |
oral
|
| gptkbp:status |
in development
|
| gptkbp:targets |
gptkb:Oncology
|
| gptkbp:type |
synthetic biotic
|
| gptkbp:bfsParent |
gptkb:Syntimmune
|
| gptkbp:bfsLayer |
6
|